| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 02/10/2005 | WO2005012294A1 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 02/10/2005 | WO2005012293A1 Phenylazole compounds, production process, and antioxidants |
| 02/10/2005 | WO2005012292A1 Gyrase inhibitors and uses thereof |
| 02/10/2005 | WO2005012291A1 3-amino choman and 2-amino tetralin derivatives |
| 02/10/2005 | WO2005012288A1 Bicyclic imidazol derivatives against flaviviridae |
| 02/10/2005 | WO2005012280A1 Alkynyl aryl carboxamides |
| 02/10/2005 | WO2005012256A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 02/10/2005 | WO2005012254A1 Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related therto |
| 02/10/2005 | WO2005012252A1 Novel 6-phenylphenantridines |
| 02/10/2005 | WO2005012246A1 Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin |
| 02/10/2005 | WO2005011709A1 Anti-viral nucleoside analogs and methods for treating viral infections, especially hiv infections |
| 02/10/2005 | WO2005011703A1 2-cyano-1,3,5-triazine-4,6-diamine derivatives |
| 02/10/2005 | WO2005011700A1 INHIBITORS OF Akt ACTIVITY |
| 02/10/2005 | WO2005011675A1 Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof |
| 02/10/2005 | WO2005011670A1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors |
| 02/10/2005 | WO2005011657A2 Piperazine derivatives and their use as therapeutic agents |
| 02/10/2005 | WO2004113357A3 Nucleoside analog inhibitors of reverse transcriptase |
| 02/10/2005 | WO2004099191A3 Benzofuranyl-and benzothienyl-piperazinyl quinolines as serotonin reuptake inhib itors |
| 02/10/2005 | WO2004093856A3 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 02/10/2005 | US20050033055 Edg receptor agonists |
| 02/10/2005 | US20050032881 Novel non-psychotropic cannabinoids |
| 02/10/2005 | US20050032875 Process for the preparation of indole derivatives |
| 02/10/2005 | US20050032874 Indole derivatives |
| 02/10/2005 | US20050032873 3-Amino chroman and 2-amino tetralin derivatives |
| 02/10/2005 | US20050032869 Antitumor, anticarcinogenic, antiproliferative, and antimetastasis agents; tyrosine kinase inhibitors; autoimmune, nervous system, neurodegenerative, and skin disorders; neurofibromatosis, atherosclerosis, graft versus host disease, glomerulonephritiis, hyperplasia; angiogenesis inhibitors |
| 02/10/2005 | US20050032866 Administering N-[(1-butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide or salt as antiarrhythmia agent |
| 02/10/2005 | US20050032860 CBI analogs of CC-1065 and the duocarmycins |
| 02/10/2005 | US20050032858 Novel heterocyclic compound and anti-inflamatory agent |
| 02/10/2005 | US20050032838 Nicotinamide derivatives useful as PDE4 inhibitors |
| 02/10/2005 | US20050032837 For therapy of irritable bowel syndrome, drug addiction or dependency, including alcohol addiction, depression, anxiety, schizophrenia, anxiety, schizophrenia and eating disorders |
| 02/10/2005 | US20050032820 Novel spiro compounds |
| 02/10/2005 | US20050032816 N-oxide anthranylamide derivatives and their use as medicaments |
| 02/10/2005 | US20050032809 5-HT receptor ligands and uses thereof |
| 02/10/2005 | US20050032805 Antimicrobial biaryl compounds |
| 02/10/2005 | US20050032798 Diaryl ureas, which release urea compound when administered to patient, for example, 1-(4-chloro-3(trifluoromethyl)phenyl)-3-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)-2-oxo-(1,3,5-perhydrotriazapine); treatment of cancer, inflammation |
| 02/10/2005 | US20050032797 Fluorinated di-aryl urea compounds |
| 02/10/2005 | US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 02/10/2005 | US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines |
| 02/10/2005 | US20050032772 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/10/2005 | US20050032738 (E)-2'-deoxy-2'-fluoromethylidenecytidine, cytidine, vinblastine, or fluorouracil; leukemia |
| 02/10/2005 | US20050030912 Use of hybrid (HW/DSP/MCU/SW) architectures for powerline OFDM communication field |
| 02/10/2005 | CA2534649A1 Bicyclic imidazol derivatives against flaviviridae |
| 02/10/2005 | CA2534263A1 Phenylazole compounds, production process and antioxidants |
| 02/10/2005 | CA2534038A1 Inhibitors of akt activity |
| 02/10/2005 | CA2533901A1 Piperazine derivatives and their use as therapeutic agents |
| 02/10/2005 | CA2533635A1 Novel 6-phenylphenantridines |
| 02/10/2005 | CA2533363A1 3-amino choman and 2-amino tetralin derivatives |
| 02/10/2005 | CA2532965A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 02/10/2005 | CA2528592A1 Novel lincomycin derivatives possessing antimicrobial activity |
| 02/10/2005 | CA2527861A1 Alkynyl aryl carboxamides |
| 02/10/2005 | CA2514466A1 Anti-viral nucleoside analogs and methods for treating viral infections, especially hiv infections |
| 02/09/2005 | EP1505067A1 4,4-disubstituted piperidine derivatives having ccr3 antagonism |
| 02/09/2005 | EP1505063A1 Benzimidazole derivatives |
| 02/09/2005 | EP1505062A1 Heterocyclic derivatives and their use as antithrombotic agents |
| 02/09/2005 | EP1503999A1 Dihydroxyhexanoic acid derivatives, their intermediates, and methods of making |
| 02/09/2005 | EP1503994A1 Substituted (thioxo)carbonylamino phenyl uraciles |
| 02/09/2005 | EP1503992A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors |
| 02/09/2005 | EP1503991A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof |
| 02/09/2005 | EP1503988A2 Fredericamycin derivatives |
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | EP1503749A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 02/09/2005 | EP1430047B1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 02/09/2005 | EP1430034B1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 02/09/2005 | EP1204322B1 Fungicides |
| 02/09/2005 | EP1105376B1 Oxindole derivatives as growth hormone releasers |
| 02/09/2005 | EP0863896B1 Novel imidazole derivatives, method for preparing same, pharmaceutical compositions and use of said derivatives as endothelin antagonists |
| 02/09/2005 | CN1578778A Tetrahydropyran derivatives and their use as therapeutic agents |
| 02/09/2005 | CN1578773A Methods and compositions of novel triazine compounds |
| 02/09/2005 | CN1578767A Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1578659A Modulators of peroxisome proliferator activated receptors (ppar) |
| 02/09/2005 | CN1576278A Colorant compounds |
| 02/09/2005 | CN1576275A Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 02/09/2005 | CN1188407C Imidazole derivatives with farnesyl transferase to inhibite activity and preparing method thereof |
| 02/09/2005 | CN1188402C Piperazinone derivs. and their uses |
| 02/09/2005 | CN1188123C Novel use of (R)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylamino methyl]-benzodihydropyran and its physiologically acceptable salts |
| 02/08/2005 | US6852752 Urea compounds, compositions and methods of use and preparation |
| 02/08/2005 | US6852734 Indole wherein A is an oxygen atom or a nitrogen atom which nitrogen atom is optionally substituted with an alkyl group, and (i) R1 and R2 each stand for a hydrogen atom or an alkyl group, independently, or (ii) R1 and R2 as taken together form |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/08/2005 | US6852717 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor; for use in therapy of diseases and pathological conditions involving inflammation such as chronic inflammatory disease |
| 02/08/2005 | US6852714 (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties |
| 02/08/2005 | US6852712 Controlling cell differentiation; antiinflammatory agents |
| 02/08/2005 | US6852711 HIV protease inhibitors |
| 02/08/2005 | CA2116830C Microbicides |
| 02/08/2005 | CA2112081C Imidazole compounds, their preparation and use |
| 02/03/2005 | WO2005009993A1 Novel compounds |
| 02/03/2005 | WO2005009978A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 02/03/2005 | WO2005009975A2 Benzimidazole derivatives as mek inhibitors |
| 02/03/2005 | WO2005009973A1 5-membered heterocycle-based p38 kinase inhibitors |
| 02/03/2005 | WO2005009971A1 Quinolone derivative or salt thereof |
| 02/03/2005 | WO2005009969A1 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 02/03/2005 | WO2005009966A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 02/03/2005 | WO2005009958A1 Ppar active compounds |
| 02/03/2005 | WO2005009957A1 Tyrosine kinase inhibitors |
| 02/03/2005 | WO2005009940A1 Novel aminobenzophenone compounds |
| 02/03/2005 | WO2005009373A2 Tyrosine kinase inhibitors |
| 02/03/2005 | WO2004106307A3 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 02/03/2005 | WO2004100998A3 Compositions and methods for non-invasive imaging of soluble beta-amyloid |
| 02/03/2005 | WO2004100881A3 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 02/03/2005 | WO2004011427A3 Substituted benzanilides as modulators of the ccr5 receptor |